WHO Issues Guideline On Use Of New HIV Treatment Drug For Pregnant Women

The World Health Organization, WHO has issued an updated recommendation on the use of new antiretroviral therapy by expectant women, stating that the risk of neural tube defects was minimal using Dolutegravir, (DTG) . The safety of dolutegravir (DTG), during

Continue reading…